Press Releases

Newly Identified PTSD Biotypes Enable Improved Screening Tools, Shed Light on Divergent Efficacy of PTSD Treatments

Researchers from the PTSD Systems Biology Consortium, led by scientists from the Walter Reed Army Institute of Research, have identified distinct biotypes for post-traumatic stress disorder, the first of their kind for any psychological disorder. “These biotypes can refine the development of screening tools and may explain the varying efficacy of PTSD treatments”, said Dr. Marti Jett, leader of the consortium and WRAIR chief scientist.

WRAIR Continues Its Fight against Drug-resistant Bacteria and Wound Infections

Though the COVID-19 pandemic remains a top priority for the U.S. Army and government’s healthcare and medical research apparatus, SARS-CoV-2 is just one of many ongoing infectious disease-related public health concerns. Antibiotic-resistant bacteria remain a significant threat to the public as well as Service Members, on and off the battlefield.

U.S. Army Advances Lead COVID-19 Vaccine Candidate

A U.S. Army laboratory, the Walter Reed Army Institute of Research, a subordinate command of the Army Futures Command’s Medical Research and Development Command, announced the selection of a lead COVID-19 vaccine candidate a two backup vaccine candidates that will advance to the next stage of research. The candidates were narrowed down from more than two dozen prototypes in order to determine the candidates that elicited the most promising antibody response in preclinical studies.